{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:55:34Z","timestamp":1781506534748,"version":"3.54.1"},"reference-count":64,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["22-15-00363"],"award-info":[{"award-number":["22-15-00363"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Placenta accreta spectrum (PAS) is a severe complication of pregnancy associated with excessive invasion of cytotrophoblast cells at the sites of the endometrial\u2013myometrial interface and the myometrium itself in cases of adherent (creta) and invasive (increta and percreta) forms, respectively. This leads to a high risk of massive blood loss, maternal hysterectomy, and preterm birth. Despite advancements in ultrasound protocols and found associations of alpha-fetoprotein, PAPP-A, hCG, PLGF, sFlt-1, IL-8, and IL-33 peripheral blood levels with PAS, there is a high need for an additional non-invasive test to improve the diagnostic accuracy and to select the real PAS from the suspected ones in the first-trimester screening. miRNA signatures of placental tissue, myometrium, and blood plasma from women with PAS in the third trimester of pregnancy, as well as miRNA profiles in exosomes from the blood serum of women in the first trimester with physiologically progressing pregnancy, complicated by PAS or pre-eclampsia, were obtained using deep sequencing. Two logistic regression models were constructed, both featuring statistically significant parameters related to the levels of miR-26a-5p, miR-17-5p, and miR-101-3p, quantified by real-time PCR in native blood serum. These models demonstrated 100% sensitivity in detecting PAS during the first pregnancy screening. These miRNAs were identified as specific markers for PAS, showing significant differences in their blood serum levels during the first trimester in the PAS group compared to those in physiological pregnancies, early- or late-onset pre-eclampsia groups. Furthermore, these miRNAs exhibited differential expression in the PAS placenta and\/or myometrium in the third trimester and, according to data from the literature, control angiogenesis. Significant correlations were found between extracellular hsa-miR-101-3p and nuchal translucency thickness, hsa-miR-17-5p and uterine artery pulsatility index, and hsa-miR-26a-5p and hsa-miR-17-5p with PLGF. The developed test system for early non-invasive PAS diagnosis based on the blood serum level of extracellular miR-26a-5p, miR-17-5p, and miR-101-3p can serve as an auxiliary method for first-trimester screening of pregnant women, subject to validation with independent test samples.<\/jats:p>","DOI":"10.3390\/ijms25020871","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T09:39:57Z","timestamp":1704879597000},"page":"871","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Diagnostic Role of Cell-Free miRNAs in Identifying Placenta Accreta Spectrum during First-Trimester Screening"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2324-9653","authenticated-orcid":false,"given":"Angelika V.","family":"Timofeeva","sequence":"first","affiliation":[{"name":"Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia, Ac. Oparina 4, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2104-5887","authenticated-orcid":false,"given":"Ivan S.","family":"Fedorov","sequence":"additional","affiliation":[{"name":"Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia, Ac. Oparina 4, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliya V.","family":"Suhova","sequence":"additional","affiliation":[{"name":"Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia, Ac. Oparina 4, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla M.","family":"Tarasova","sequence":"additional","affiliation":[{"name":"Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia, Ac. Oparina 4, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa S.","family":"Ezhova","sequence":"additional","affiliation":[{"name":"Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia, Ac. Oparina 4, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana M.","family":"Zabelina","sequence":"additional","affiliation":[{"name":"Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia, Ac. Oparina 4, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana N.","family":"Vasilchenko","sequence":"additional","affiliation":[{"name":"Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia, Ac. Oparina 4, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7990-0276","authenticated-orcid":false,"given":"Tatyana Y.","family":"Ivanets","sequence":"additional","affiliation":[{"name":"Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia, Ac. Oparina 4, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennady T.","family":"Sukhikh","sequence":"additional","affiliation":[{"name":"Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia, Ac. Oparina 4, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ajog.2017.05.067","article-title":"Placenta accreta spectrum: Pathophysiology and evidence-based anatomy for prenatal ultrasound imaging","volume":"218","author":"Jauniaux","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/GRF.0000000000000391","article-title":"The Placenta Accreta Spectrum: Epidemiology and Risk Factors","volume":"61","author":"Carusi","year":"2018","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/aogs.12080","article-title":"Placenta accreta: Incidence and risk factors in an area with a particularly high rate of cesarean section","volume":"92","author":"Morlando","year":"2013","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"534.e1","DOI":"10.1016\/j.ajog.2021.04.233","article-title":"Trends, characteristics, and outcomes of placenta accreta spectrum: A national study in the United States","volume":"225","author":"Matsuzaki","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.ajog.2004.12.074","article-title":"Abnormal placentation: Twenty-year analysis","volume":"192","author":"Wu","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ijgo.12948","article-title":"A systematic review and meta-analysis of cesarean delivery and other uterine surgery as risk factors for placenta accreta","volume":"147","author":"Serruya","year":"2019","journal-title":"Int. J. Gynaecol. Obstet. Off. Organ Int. Fed. Gynaecol. Obstet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/1471-0528.13547","article-title":"Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: Results from a large population-based pregnancy cohort study in the Nordic countries","volume":"123","author":"Thurn","year":"2016","journal-title":"BJOG"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ijgo.12407","article-title":"FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology","volume":"140","author":"Jauniaux","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.placenta.2011.11.010","article-title":"Placenta accreta: Pathogenesis of a 20th century iatrogenic uterine disease","volume":"33","author":"Jauniaux","year":"2012","journal-title":"Placenta"},{"key":"ref_10","first-page":"1795","article-title":"Placenta accreta: Diagnosis, management and the molecular biology of the morbidly adherent placenta","volume":"29","author":"Goh","year":"2016","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/GRF.0000000000000392","article-title":"Pathophysiology of placenta accreta spectrum disorders: A review of current findings","volume":"61","author":"Jauniaux","year":"2018","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ma, J., Liu, Y., Guo, Z., Sun, R., Yang, X., Zheng, W., Ma, Y., Rong, Y., Wang, H., and Yang, H. (2022). The diversity of trophoblast cells and niches of placenta accreta spectrum disorders revealed by single-cell RNA sequencing. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.1044198"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"411.e1","DOI":"10.1016\/j.ajog.2010.12.027","article-title":"Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast","volume":"204","author":"Wehrum","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Krstic, J., Deutsch, A., Fuchs, J., Gauster, M., Gorsek Sparovec, T., Hiden, U., Krappinger, J.C., Moser, G., Pansy, K., and Szmyra, M. (2022). (Dis)similarities between the Decidual and Tumor Microenvironment. Biomedicines, 10.","DOI":"10.3390\/biomedicines10051065"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ogc.2015.01.014","article-title":"Placenta accreta spectrum: Accreta, increta, and percreta","volume":"42","author":"Silver","year":"2015","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1068377","DOI":"10.3389\/frph.2023.1068377","article-title":"Absence of abnormal vascular changes on prenatal imaging aids in differentiating simple uterine scar dehiscence from placenta accreta spectrum: A case series","volume":"5","author":"Owusu","year":"2023","journal-title":"Front. Reprod. Health"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ajog.2016.07.044","article-title":"Accreta placentation: A systematic review of prenatal ultrasound imaging and grading of villous invasiveness","volume":"215","author":"Jauniaux","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/ajo.13471","article-title":"Placenta accreta spectrum: We can do better","volume":"62","author":"Silveira","year":"2022","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"ref_19","first-page":"1090","article-title":"Relationship between the Prenatal Diagnosis of Placenta Acreta Spectrum and Lower Use of Blood Components","volume":"44","author":"Altamirano","year":"2022","journal-title":"Rev. Bras. Ginecol. Obstet. Rev. Fed. Bras. Soc. Ginecol. Obstet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e16241","DOI":"10.1016\/j.heliyon.2023.e16241","article-title":"The prenatal diagnostic indicators of placenta accreta spectrum disorders","volume":"9","author":"Wu","year":"2023","journal-title":"Heliyon"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"860186","DOI":"10.3389\/fmed.2022.860186","article-title":"Potential Serum Biomarkers in Prenatal Diagnosis of Placenta Accreta Spectrum","volume":"9","author":"Zhang","year":"2022","journal-title":"Front. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1515\/jpm-2019-0261","article-title":"Significance of the routine first-trimester antenatal screening program for aneuploidy in the assessment of the risk of placenta accreta spectrum disorders","volume":"48","author":"Penzhoyan","year":"2019","journal-title":"J. Perinat. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000492829","article-title":"Second Trimester Biochemical Markers as Possible Predictors of Pathological Placentation: A Retrospective Case-Control Study","volume":"46","author":"Berezowsky","year":"2019","journal-title":"Fetal Diagn. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00404-020-05960-1","article-title":"First trimester serum PAPP-A is associated with placenta accreta: A retrospective study","volume":"303","author":"Wang","year":"2021","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e34473","DOI":"10.1097\/MD.0000000000034473","article-title":"Meta-analysis for the relationship between circulating pregnancy-associated plasma protein A and placenta accreta spectrum","volume":"102","author":"Li","year":"2023","journal-title":"Medicine"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ijgo.12352","article-title":"Second-trimester levels of fetoplacental hormones among women with placenta accreta spectrum disorders","volume":"140","author":"Melcer","year":"2018","journal-title":"Int. J. Gynaecol. Obstet. Off. Organ Int. Fed. Gynaecol. Obstet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.placenta.2020.08.023","article-title":"First trimester serum PIGF is associated with placenta accreta","volume":"101","author":"Wang","year":"2020","journal-title":"Placenta"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1080\/01443615.2021.1955337","article-title":"Predictive value of vascular endothelial growth factor and placenta growth factor for placenta accreta spectrum","volume":"42","author":"Faraji","year":"2022","journal-title":"J. Obstet. Gynaecol. J. Inst. Obstet. Gynaecol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.placenta.2022.05.009","article-title":"Distinguishing placenta accreta from placenta previa via maternal plasma levels of sFlt-1 and PLGF and the sFlt-1\/PLGF ratio","volume":"124","author":"Zhang","year":"2022","journal-title":"Placenta"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.placenta.2020.01.007","article-title":"Biomarkers of abnormally invasive placenta","volume":"91","author":"Youssef","year":"2020","journal-title":"Placenta"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1080\/14767058.2019.1679766","article-title":"Increased levels of serum IL-33 is associated with adverse maternal outcomes in placenta previa accreta","volume":"34","author":"Ozler","year":"2021","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/19336918.2015.1098800","article-title":"Potential role of epigenetic mechanisms in regulation of trophoblast differentiation, migration, and invasion in the human placenta","volume":"10","author":"Kadam","year":"2016","journal-title":"Cell Adh. Migr."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Kannampuzha, S., Ravichandran, M., Mukherjee, A.G., Wanjari, U.R., Renu, K., Vellingiri, B., Iyer, M., Dey, A., George, A., and Gopalakrishnan, A.V. (2022). The mechanism of action of non-coding RNAs in placental disorders. Biomed. Pharmacother., 156.","DOI":"10.1016\/j.biopha.2022.113964"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1021640","DOI":"10.3389\/fendo.2023.1021640","article-title":"Identification of altered miRNAs and their targets in placenta accreta","volume":"14","author":"Barth","year":"2023","journal-title":"Front. Endocrinol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.placenta.2020.09.068","article-title":"Serum miRNA biomarker discovery for placenta accreta spectrum","volume":"101","author":"Chen","year":"2020","journal-title":"Placenta"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"919","DOI":"10.21037\/atm-20-1150","article-title":"Development and validation of a four-microRNA signature for placenta accreta spectrum: An integrated competing endogenous RNA network analysis","volume":"8","author":"Yang","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Rossi-Herring, G., Belmonte, T., Rivas-Urbina, A., Ben\u00edtez, S., Rotllan, N., Crespo, J., Llorente-Cort\u00e9s, V., S\u00e1nchez-Quesada, J.L., and de Gonzalo-Calvo, D. (2023). Circulating lipoprotein-carried miRNome analysis reveals novel VLDL-enriched microRNAs that strongly correlate with the HDL-microRNA profile. Biomed. Pharmacother., 162.","DOI":"10.1016\/j.biopha.2023.114623"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Timofeeva, A.V., Fedorov, I.S., Sukhova, Y.V., Ivanets, T.Y., and Sukhikh, G.T. (2023). Prediction of Early- and Late-Onset Pre-Eclampsia in the Preclinical Stage via Placenta-Specific Extracellular miRNA Profiling. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24098006"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/15476286.2019.1582956","article-title":"Extracellular microRNAs exhibit sequence-dependent stability and cellular release kinetics","volume":"16","author":"Pauwels","year":"2019","journal-title":"RNA Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/ATVBAHA.112.300139","article-title":"Intercellular transport of microRNAs","volume":"33","author":"Boon","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2153034","DOI":"10.1080\/14767058.2022.2153034","article-title":"Soluble suppression of tumorigenicity-2 in pregnancy with a small-for-gestational-age fetus and with preeclampsia","volume":"36","author":"Kanninen","year":"2023","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1009867","DOI":"10.3389\/fimmu.2023.1009867","article-title":"The central role of natural killer cells in preeclampsia","volume":"14","author":"Wei","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e76319","DOI":"10.7554\/eLife.76319","article-title":"Natural killer (NK) cell-derived extracellular-vesicle shuttled microRNAs control T cell responses","volume":"11","author":"Dosil","year":"2022","journal-title":"Elife"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/jog.13560","article-title":"MiRNA-320a inhibits trophoblast cell invasion by targeting estrogen-related receptor-gamma","volume":"44","author":"Gao","year":"2018","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_45","first-page":"3256","article-title":"miR-320a upregulation contributes to the development of preeclampsia by inhibiting the growth and invasion of trophoblast cells by targeting interleukin 4","volume":"20","author":"Xie","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejogrb.2021.06.032","article-title":"Clinical significance of microRNA-320a and insulin-like growth factor-1 receptor in early-onset preeclampsia patients","volume":"263","author":"Liao","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1530\/REP-20-0309","article-title":"Ligustrazine-induced microRNA-16-5p inhibition alleviates preeclampsia through IGF-2","volume":"160","author":"Yuan","year":"2020","journal-title":"Reproduction"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Rekowska, A.K., Obuchowska, K., Bartosik, M., Kimber-Trojnar, \u017b., S\u0142odzi\u0144ska, M., Wierzchowska-Opoka, M., and Leszczy\u0144ska-Gorzelak, B. (2023). Biomolecules Involved in Both Metastasis and Placenta Accreta Spectrum-Does the Common Pathophysiological Pathway Exist?. Cancers, 15.","DOI":"10.3390\/cancers15092618"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1089\/ars.2014.5856","article-title":"Hypoxia-responsive microRNA-101 promotes angiogenesis via heme oxygenase-1\/vascular endothelial growth factor axis by targeting cullin 3","volume":"21","author":"Kim","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Tokarski, M., Cierzniak, A., and Baczynska, D. (2022). Role of hypoxia on microRNA-dependant regulation of HGFA\u2014HGF\u2014c-Met signalling pathway in human progenitor and mature endothelial cells. Int. J. Biochem. Cell Biol., 152.","DOI":"10.1016\/j.biocel.2022.106310"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1161\/01.RES.0000157575.66295.e0","article-title":"HGF and VEGF: A dynamic duo","volume":"96","author":"Gerritsen","year":"2005","journal-title":"Circ. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/1566523043346453","article-title":"Therapeutic angiogenesis using hepatocyte growth factor (HGF)","volume":"4","author":"Morishita","year":"2004","journal-title":"Curr. Gene Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12672-021-00437-2","article-title":"Extracellular vesicle-derived miR-320a targets ZC3H12B to inhibit tumorigenesis, invasion, and angiogenesis in ovarian cancer","volume":"12","author":"Huang","year":"2021","journal-title":"Discov. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.canlet.2017.03.004","article-title":"Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis","volume":"397","author":"Zhang","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"300060519896144","DOI":"10.1177\/0300060519896144","article-title":"Decreased serum exosomal miR-320a expression is an unfavorable prognostic factor in patients with hepatocellular carcinoma","volume":"48","author":"Hao","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"112113","DOI":"10.1016\/j.yexcr.2020.112113","article-title":"Extracellular vesicle encapsulated microRNA-320a inhibits endometrial cancer by suppression of the HIF1\u03b1\/VEGFA axis","volume":"394","author":"Zhang","year":"2020","journal-title":"Exp. Cell Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s13287-023-03530-1","article-title":"Extracellular vesicles derived from human ESC-MSCs target macrophage and promote anti-inflammation process, angiogenesis, and functional recovery in ACS-induced severe skeletal muscle injury","volume":"14","author":"Jiang","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Pan, Q., Xu, X., He, W., Wang, Y., Xiang, Z., Jin, X., Tang, Q., Zhao, T., and Ma, X. (2023). Enrichment of miR-17-5p enhances the protective effects of EPC-EXs on vascular and skeletal muscle injury in a diabetic hind limb ischemia model. Biol. Res., 56.","DOI":"10.1186\/s40659-023-00418-5"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41419-021-03986-0","article-title":"Retinoblastoma cell-derived exosomes promote angiogenesis of human vesicle endothelial cells through microRNA-92a-3p","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc3582","article-title":"Kr\u00fcppel-like factors in cancer","volume":"13","author":"Tetreault","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Langmead, B., Trapnell, C., Pop, M., and Salzberg, S.L. (2009). Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol., 10.","DOI":"10.1186\/gb-2009-10-3-r25"},{"key":"ref_62","unstructured":"Team, R.C. (2021, March 10). A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. Available online: https:\/\/www.r-project.org."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Love, M.I., Huber, W., and Anders, S. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol., 15.","DOI":"10.1186\/s13059-014-0550-8"},{"key":"ref_64","unstructured":"RS Team (2021, March 23). RStudio: Integrated Development for R. RStudio. Available online: http:\/\/www.rstudio.com\/."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/2\/871\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:43:52Z","timestamp":1760103832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/2\/871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,10]]},"references-count":64,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["ijms25020871"],"URL":"https:\/\/doi.org\/10.3390\/ijms25020871","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,10]]}}}